Jiangxi Fushine Pharmaceutical Co., Ltd.

SZSE:300497.SZ

10.05 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -223.256-164.17539.538322.179306.88192.362174.477172.5293.60253.44145.07340.0790
Depreciation & Amortization 159.459123.83898.56873.93366.52752.83445.19734.1728.50223.23517.47810.2470
Deferred Income Tax -4.707-0.723-18.161-3.7961.714-1.6113.431-2.62-1.0830000
Stock Based Compensation 01.6576.3200.7724.85315.5715.98300000
Change In Working Capital -122.988-301.976-233.301-73.498-98.964-109.379-22.867-25.219-66.469-54.219-12.218-1.8770
Accounts Receivables -159.446-273.946-199.386-152.728-149.721-92.825-36.89-26.813-39.336-26.0943.84600
Inventory 74.55-259.581-154.854-52.367-28.825-22.98-26.881-44.7735.498-35.758-18.8679.5730
Accounts Payables -33.385232.274139.099135.39377.8688.03527.47248.987-31.5490000
Other Working Capital 7.031-0.723-18.161-3.7961.714-86.3994.01419.554-71.968-18.466.649-11.450
Other Non Cash Items 39.029221.462167.51659.73763.46940.09813.9177.06318.3748.9326.88614.7460
Operating Cash Flow -64.763-120.85172.322382.351337.911175.914210.723188.53474.00931.3957.21963.1960
Investing Activities:
Investments In Property Plant And Equipment -242.225-459.411-679.597-449.237-324.901-163.887-98.995-81.336-73.744-51.862-75.6-51.243-82.212
Acquisitions Net 1.613.8070.296457.124325.487-1.387-10.2720.290.75400-7.719-4
Purchases Of Investments -161.7-302.8-520.859-208.251-130-306.35-490-3140000.0260.014
Sales Maturities Of Investments 47.813250.069448.478101.1102.863310.186537.881141.9970.3280.910.890.8840.645
Other Investing Activites -112.277016.198-449.237-324.90100.9471.0821.4741.1650.133-21.18748.109
Investing Cash Flow -354.502-508.335-735.484-548.501-351.453-161.437-60.439-252.257-71.943-49.788-74.577-79.265-37.459
Financing Activities:
Debt Repayment -206.044-830.488-488.5-596.5-716.996-421.338-212.575-198.2-167.634-151.02-114.89-102.195-57.242
Common Stock Issued -0.37772.944105.113-1.15996.91800000000
Common Stock Repurchased -20.536-72.944-105.1131.159-96.918-3.1030000000
Dividends Paid -55.79-54.581-110.001-56.764-43.914-79.742-70.839-45.331-32.84-9.852-9.353-7.098-5.623
Other Financing Activities -0.4891,168.056977.291,591.087826.313670.828370.688272.345491.402176.94139.457140.10584.789
Financing Cash Flow 149.765282.987349.611912.69130.818169.74887.27428.814290.92816.06815.21330.81221.923
Other Information:
Effect Of Forex Changes On Cash 3.0039.510.737-8.603-0.0054.378-3.0833.698-0.0310000
Net Change In Cash -266.497-336.689-312.815737.93717.271188.603234.476-31.21292.962-2.33-2.14514.74318.262
Cash At End Of Period 580.755847.2531,183.9421,496.756758.819741.548552.945318.469349.67956.71759.04761.19246.449